Nasdaq threatens Cedara delisting

Article

Canadian software developer Cedara has been notified by Nasdaq that the company does not comply with basic criteria to maintain its listing on the Nasdaq Small Cap stock exchange. Stock price and stockholder equity have dropped below minimums, according

Canadian software developer Cedara has been notified by Nasdaq that the company does not comply with basic criteria to maintain its listing on the Nasdaq Small Cap stock exchange. Stock price and stockholder equity have dropped below minimums, according to the company. Cedara plans to request a hearing before a Nasdaq Listing Qualifications Panel to review the determination and to discuss potential actions to achieve compliance.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.